The Metabolomic View of Systemic Sclerosis—A Systematic Literature Review
The mortality risk in systemic sclerosis (SSc) is primarily determined by pulmonary involvement (interstitial lung disease (ILD), pulmonary fibrosis), pulmonary arterial hypertension (PAH), and cardiac involvement. With timely and intensive treatment, the disease can be halted or even improved. Ther...
Saved in:
| Main Authors: | Sebastian T. Jendrek, Franziska Schmelter, Christian Sina, Ulrich L. Günther, Gabriela Riemekasten |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Sclerosis |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-3064/3/2/18 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NMR based clinical metabolomics revealed altered lipid and sugar metabolism in systemic sclerosis with implications for diagnosis and therapeutic strategies
by: Gurvinder Singh, et al.
Published: (2025-08-01) -
The Current Applications of Metabolomics in Understanding Endometriosis: A Systematic Review
by: Blake Collie, et al.
Published: (2025-01-01) -
Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis
by: Martin Diebold, et al.
Published: (2022-12-01) -
Metabolomics Analysis as a Tool in Periodontitis Diagnosis: A Systematic Review
by: Ana‐Maria Condor, et al.
Published: (2025-02-01) -
Comprehensive clinical and metabolomics profiling of COVID-19 Mexican patients across three epidemiological waves
by: David Alejandro García-López, et al.
Published: (2025-06-01)